Noted Hedge Fund Manager Takes Significant Stake In This Off The Radar Small Cap

Today we take an in-depth look at Catalyst Bioscciences after Point 72 disclosed an over 5% stake in small biotech firm

The truth does not change according to our ability to stomach it.” ― Flannery O'Connor

Note: To comment on this article or to get and read these full articles free to your ‘in box’ as published, just hit the + Follow button in the upper right-hand corner of this site.